Bibliography

Found 63 results

Filters: Author is Ronald J Ellis [Clear All Filters]

Book Chapter

Ellis RJ, Merdes A, Masliah E, Langford TD. Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy. In: Gendelman, H.E.; Grant ELSI ; I ; The Neurology of AIDS. The Neurology of AIDS. London: Oxford University Press; 2005. pp. 799-809.

Conference Paper

Cherner M, Masliah E, Heaton RK, Ellis RJ, Marcotte TD, McCutchan JA, Grant I, HNRC. Association between HIV encephalitis, neurodegeneration and neurocognitive dysfunction. In: Journal of Neurovirology. Vol. 6. Journal of Neurovirology. ; 2000. p. 50.

Wiederin J, Rozek W, Pan H, Jagadish T, Banerjee S, Vaida F, Letendre S, Ellis RJ, Grant I, Fox HS, et al. Proteomic fingerprints in CSF and blood of HIV-infected patients with neurocognitive disorders. In: The 9th International Symposium on NeuroVirology. The 9th International Symposium on NeuroVirology. Miami Beach, FL; 2009.

Letendre S, Ellis RJ, Grant I, McCutchan JA, HNRC. The relationship between levels of CD4+ counts and HIV-1 RNA in CSF and plasma in 900 samples. In: Eighth Conference on Retroviruses and Opportunistic Infections. Eighth Conference on Retroviruses and Opportunistic Infections. ; 2001.

Cherner M, Moore D, Masliah E, Ellis RJ, Heaton RK, Grant I, HNRC. Relationship between neuropsyhchological impairment and post-mortem findings of HIV-associated brain disease. In: Journal of the International Neuropsyhcological Society. Vol. 8. Journal of the International Neuropsyhcological Society. ; 2002. p. 314.

Childers ME, Ellis RJ, Deutsch R, Heaton RK, Wolfson TJ, Grant I, HNRC. The utility and limitations of the HIV Dementia Scale. In: Journal of the International Neuropsychological Society. Vol. 8. Journal of the International Neuropsychological Society. ; 2001. p. 160.

Marquie-Beck J, Ellis RJ, Langford D, Childers ME, Rippeth JD, Letendre S, Lazzaretto D, Masliah E. Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. p. 130.

Cherner M, Masliah E, Heaton RK, Ellis RJ, Grant I, HNRC. Value of neurocognitive status in predicting HIV-related brain disease. In: Journal of the International Neuropsychological Society. Vol. 7. Journal of the International Neuropsychological Society. ; 2001. p. 150.

Journal Article

Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis RJ, Letendre S, Patrick C, Adame A, et al. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993

Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen LA, Masliah E. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. Journal of Neuropathology and Experimental Neurology [Internet]. 2004 ;63(10):1038-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15535131

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

Woods SPaul, Childers ME, Ellis RJ, Guaman S, Grant I, Heaton RK. A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2006 ;21(1):83-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16169705

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez RG, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458

Singh K, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):185-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579296

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis RJ, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. Journal of NeuroVirology [Internet]. 2014 ;20(4):371-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24817145

Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson DM, Yiannoutsos CT, et al. Clinical validation of the NeuroScreen. Journal of Neurovirology [Internet]. 2005 ;11(6):503-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16338744

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693

Chana G, Everall I, Crews LA, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton RK, Ellis RJ, et al. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology [Internet]. 2006 ;67(8):1486-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17060582

Gonzalez RG, Heaton RK, Moore D, Letendre S, Ellis RJ, Wolfson TJ, Marcotte TD, Cherner M, Rippeth JD, Grant I, et al. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359

Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. Journal of Acquired Immune Deficiency Syndromes . 2019 ;81.

Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Pages